Connor, Clark & Lunn Investment Management (CC&L)’s NEVRO CORP. NVRO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,702	Closed	-$140K	–	1641
2024 Q4	$140K	Buy	+37,702	New	+$174K	﹤0.01%	1352
2024 Q2	–	Sell	-18,464	Closed	-$267K	–	1741
2024 Q1	$267K	Buy	+18,464	New	+$305K	﹤0.01%	1310
2023 Q4	–	Sell	-14,428	Closed	-$277K	–	1597
2023 Q3	$277K	Sell	14,428 -14,299	-50%	-$305K	﹤0.01%	1162
2023 Q2	$730K	Sell	28,727 -24,812	-46%	-$716K	﹤0.01%	883
2023 Q1	$1.94M	Sell	53,539 -5,180	-9%	-$182K	0.01%	561
2022 Q4	$2.33M	Buy	58,719 +32,849	+127%	+$1.37M	0.01%	506
2022 Q3	$1.21M	Buy	25,870 +997	+4%	+$46.3K	0.01%	609
2022 Q2	$1.09M	Buy	24,873 +1,479	+6%	+$81.3K	0.01%	602
2022 Q1	$1.69M	Buy	+23,394	New	+$1.69M	0.01%	538

Other funds holding NVRO

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NVRO Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 37,702 shares — an estimated $140K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NVRO in Q1 2022 and held it in 9 quarters. The position peaked at $2.33M in Q4 2022. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 37,702 NEVRO CORP. shares in Q1 2025, an estimated $140K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NEVRO CORP. in Q1 2022 and held it in 9 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s NEVRO CORP. position peaked at $2.33M in Q4 2022.
126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.